[Congress] 2019 Drug Discovery Chemistry - 8-12 April 2019 - San Diego - USA

[TALK] & [STAND 321] to figure out how we can support you in your drug development!

2019 Drug Discovery Chemistry-  8-12 Avril 2019 - San Diego

TALK

Alexis Denis, Head of Discovery, will talk about Nanocyclix platform!

When: 10th April, 2019 - 8.35 am - Stream Kinase Inhibitor Chemistry

Make it cyclic: A paradigm for the discovery of selective kinases inhibitors “Nanocyclix”

"Cyclization in drug discovery is a growing paradigm. We have developed an Integrated Drug Discovery platform Nanocyclix to synthesize small libraries of macrocycles and design specific molecules through SBDD to identify new kinases inhibitor. Nanocyclix molecule are in the drug-like space and display nM potencies and good selectivity across the kinome.  Nanocyclix paradigm will be exemplified at the level of H2L and beyond in Oncology and Immuno-inflammation to illustrate the value and potential of the cyclization approach."

BOOTH

Discuss directly with our experts at [BOOTH 321] to figure out how to access our Integrated Drug Discovery engine for high quality candidate drugs within less than 3 years!

Download our flyer!    This email address is being protected from spambots. You need JavaScript enabled to view it.

[Congress] 2019 Immuno- Oncology Summit Europe 2019 - March 18-22- London- UK -

Explore our solutions from hit identification to drug candidate!

Immuno-Oncology Summit Europe

Josselin Caradec, Head of in vitro laboratory and Program Director will present its poster related to the development of pre-clinical assay in Immuno-Oncology.

POSTER - "Development of Pre-Clinical Assays to Support Drug Discovery Programs in Immuno-Oncology"

Dates : March 20 and 21
Session : Preclinical and Translational Immuno-Oncology
Poster Session B

I want to fix a meeting

It is the largest & most informative healthcare investment symposium in the industry!

2019 J.P. Morgan Health Care Investor Conference - January 7–10, 2019 | San Francisco

We will be there to introduce our expertise in macrocyclization of small Lead-like molecules & our R&D kinase inhibitor programs available under adhoc agreements.

 Fabrice Viviani - Experimentation Strategic Activity Director will be available to fix meetings

This email address is being protected from spambots. You need JavaScript enabled to view it.

%MCEPASTEBIN%

 

 

 

2-day conference on Immunotherapies for prevention and treatment of infectious diseases!

Web I4ID event immunotherapies

 Come and meet Emilie Soulier - Business Account Manager - to discuss your project and find out how Oncodesign's immuno services can support your program!

This email address is being protected from spambots. You need JavaScript enabled to view it.

%MCEPASTEBIN%

By closing this message, you consent to our cookies on this device in accordance with our cookie policy unless you have disabled them.